504

Compound name
Capivasertib
Alt Name
capivasertib
AZD5363
1143532-39-1
AZD-5363
AZD 5363
Compound Image
capivasertib_1.png
SMILES
ClC1=CC=C([C@H](CCO)NC(C2(CCN(C3=C4C(NC=C4)=NC=N3)CC2)N)=O)C=C1
MW
428.90
Brutto
C21HClN256O2
InChI
InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1
InChI Key
JDUBGYFRJFOXQC-KRWDZBQOSA-N
Approval Jurisdiction
2023 FDA
Approved for clinical use
HR+ And PI3K Mutation Breast Cancer
CAS
1143532-39-1
PubChem CID
25227436
Action
AKT
Approved Drug List
1